Liminal BioSciences Inc. Aktie Toronto S.E.
Aktien
A2PTG9
CA53272L1031
LMNL
Biotechnologie
Zuletzt veröffentlichtes Transkript: Liminal BioSciences Inc.
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 51 | 14.07.08 | |
Director of Finance/CFO | 51 | 02.03.22 | |
Patrick Sartore
PSD | President | 49 | 01.01.06 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01.05.19 |
Director/Board Member | 67 | 14.05.14 | |
Alek Krstajic
CHM | Chairman | 60 | 01.09.20 |
% 1. Jan. | Kap. | |
---|---|---|
+25.69% | 47.9 Mrd. | |
+46.90% | 41.42 Mrd. | |
-3.46% | 40.7 Mrd. | |
-6.20% | 28.92 Mrd. | |
+9.17% | 25.55 Mrd. | |
-20.42% | 19.27 Mrd. | |
+0.17% | 12.15 Mrd. | |
+28.07% | 12.14 Mrd. | |
-1.24% | 11.99 Mrd. |